Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001779934-26-000002

Options or other derivatives

  • Director acquired 6,090 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McGeorge Anne Director 2026-05-21 Grant or award · Stock Option (Right to Buy) +6,090 6,090 D
Loading xslF345X06/ownership.xml…